Profile
Paolo Galfetti is Chief Executive Officer & Director at APR Applied Pharma Research SA since 1995.
Mr. Galfetti is Chief Business Officer at Mindmaze Therapeutics Holding SA. Former roles include Chief Executive Officer & Director at Farma Resa Imp SRL, Chief Executive Officer & Director at Institute For Pharmacokinetic & Analytical Studies, and Chief Operating Officer at RELIEF THERAPEUTICS Holding SA from 2023 to 2024.
Education includes an undergraduate degree from the University of Bocconi.
Paolo Galfetti active positions
| Companies | Position | Start |
|---|---|---|
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology Develops and licenses healthcare products and technologies | Chief Executive Officer | 31/12/1994 |
Former positions of Paolo Galfetti
| Companies | Position | End |
|---|---|---|
Institute For Pharmacokinetic & Analytical Studies | Chief Executive Officer | - |
Farma Resa Imp SRL
Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Specializes in preparation of pharmaceutical tests | Chief Executive Officer | - |
| MINDMAZE THERAPEUTICS HOLDING SA | Chief Operating Officer | 07/05/2024 |
Training of Paolo Galfetti
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Farma Resa Imp SRL
Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Specializes in preparation of pharmaceutical tests | Health Technology |
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology Develops and licenses healthcare products and technologies | Health Technology |
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
Institute For Pharmacokinetic & Analytical Studies |
- Stock Market
- Insiders
- Paolo Galfetti
















